HUP0203383A3 - Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof - Google Patents
Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereofInfo
- Publication number
- HUP0203383A3 HUP0203383A3 HU0203383A HUP0203383A HUP0203383A3 HU P0203383 A3 HUP0203383 A3 HU P0203383A3 HU 0203383 A HU0203383 A HU 0203383A HU P0203383 A HUP0203383 A HU P0203383A HU P0203383 A3 HUP0203383 A3 HU P0203383A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical composition
- composition containing
- aminophenoxyacetamide derivatives
- aminophenoxyacetamide
- derivatives
- Prior art date
Links
- AHZPJIGLXKMUCO-UHFFFAOYSA-N 2-amino-2-phenoxyacetamide Chemical class NC(=O)C(N)OC1=CC=CC=C1 AHZPJIGLXKMUCO-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000112100 | 2000-04-13 | ||
| PCT/JP2001/003198 WO2001079170A2 (en) | 2000-04-13 | 2001-04-13 | Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0203383A2 HUP0203383A2 (hu) | 2003-02-28 |
| HUP0203383A3 true HUP0203383A3 (en) | 2003-11-28 |
Family
ID=18624324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0203383A HUP0203383A3 (en) | 2000-04-13 | 2001-04-13 | Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7067533B2 (OSRAM) |
| EP (1) | EP1228367B1 (OSRAM) |
| JP (1) | JP2004501079A (OSRAM) |
| KR (1) | KR100853968B1 (OSRAM) |
| CN (1) | CN1264821C (OSRAM) |
| AT (1) | ATE374366T1 (OSRAM) |
| AU (1) | AU784930B2 (OSRAM) |
| CA (1) | CA2370487A1 (OSRAM) |
| DE (1) | DE60130628T2 (OSRAM) |
| ES (1) | ES2291308T3 (OSRAM) |
| HU (1) | HUP0203383A3 (OSRAM) |
| WO (1) | WO2001079170A2 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030186963A1 (en) | 2001-09-14 | 2003-10-02 | Dorwald Florencio Zaragoza | Substituted piperidines |
| WO2003024929A1 (en) * | 2001-09-14 | 2003-03-27 | Novo Nordisk A/S | Substituted piperidines with selective binding to histamine h3-receptor |
| EP1968961A2 (en) | 2005-12-21 | 2008-09-17 | Decode Genetics EHF | Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| DE102005062990A1 (de) * | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln |
| CN101730691A (zh) * | 2007-04-27 | 2010-06-09 | 阿斯比奥制药株式会社 | 含氮芳香族六元环衍生物及含有它们的药物 |
| CA3001857A1 (en) * | 2015-10-14 | 2017-04-20 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use against stress granules |
| EP3468960B1 (en) | 2016-06-08 | 2022-03-23 | GlaxoSmithKline Intellectual Property Development Limited | Chemical compounds as atf4 pathway inhibitors |
| CN111285820A (zh) * | 2018-12-07 | 2020-06-16 | 成都康弘药业集团股份有限公司 | 一种枸橼酸莫沙必利有关物质及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW204411B (OSRAM) * | 1991-06-05 | 1993-04-21 | Tokyo Electron Co Ltd | |
| EP0982026B1 (en) | 1998-08-18 | 2006-05-17 | F. Hoffmann-La Roche Ag | Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers |
| DE69918404T2 (de) * | 1998-10-16 | 2005-08-04 | Daiichi Suntory Pharma Co., Ltd. | Aminophenoxyessigsäure derivate als neuroschützende mittel |
-
2001
- 2001-04-13 CA CA002370487A patent/CA2370487A1/en not_active Abandoned
- 2001-04-13 HU HU0203383A patent/HUP0203383A3/hu unknown
- 2001-04-13 AT AT01921835T patent/ATE374366T1/de not_active IP Right Cessation
- 2001-04-13 JP JP2001576772A patent/JP2004501079A/ja not_active Abandoned
- 2001-04-13 CN CNB018009085A patent/CN1264821C/zh not_active Expired - Fee Related
- 2001-04-13 WO PCT/JP2001/003198 patent/WO2001079170A2/en not_active Ceased
- 2001-04-13 EP EP01921835A patent/EP1228367B1/en not_active Expired - Lifetime
- 2001-04-13 KR KR1020017015979A patent/KR100853968B1/ko not_active Expired - Fee Related
- 2001-04-13 AU AU48762/01A patent/AU784930B2/en not_active Ceased
- 2001-04-13 US US10/009,566 patent/US7067533B2/en not_active Expired - Fee Related
- 2001-04-13 DE DE60130628T patent/DE60130628T2/de not_active Expired - Fee Related
- 2001-04-13 ES ES01921835T patent/ES2291308T3/es not_active Expired - Lifetime
-
2006
- 2006-01-24 US US11/337,664 patent/US20060178401A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1228367A2 (en) | 2002-08-07 |
| DE60130628D1 (de) | 2007-11-08 |
| KR20020016830A (ko) | 2002-03-06 |
| AU4876201A (en) | 2001-10-30 |
| WO2001079170A3 (en) | 2002-06-13 |
| ES2291308T3 (es) | 2008-03-01 |
| US7067533B2 (en) | 2006-06-27 |
| JP2004501079A (ja) | 2004-01-15 |
| HUP0203383A2 (hu) | 2003-02-28 |
| CA2370487A1 (en) | 2001-10-25 |
| WO2001079170A2 (en) | 2001-10-25 |
| KR100853968B1 (ko) | 2008-08-25 |
| ATE374366T1 (de) | 2007-10-15 |
| CN1449493A (zh) | 2003-10-15 |
| US20030139447A1 (en) | 2003-07-24 |
| DE60130628T2 (de) | 2008-07-10 |
| AU784930B2 (en) | 2006-08-03 |
| US20060178401A1 (en) | 2006-08-10 |
| EP1228367B1 (en) | 2007-09-26 |
| CN1264821C (zh) | 2006-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL152451A0 (en) | 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same | |
| HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
| IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
| HUP0301269A3 (en) | Phthalazinone derivatives and pharmaceutical compositions containing them | |
| IL151372A0 (en) | Cyclopropyl-fused pyrrolidine derivatives and pharmaceutical compositions containing the same | |
| IL152718A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
| HUP0400837A3 (en) | 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them | |
| HUP0204474A3 (en) | 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use | |
| GC0000307A (en) | Pyrimidone compounds and pharmaceutical composition containing them | |
| HUP0302550A3 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them | |
| IL155196A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
| HUP0302997A3 (en) | Phenylalanine derivatives with alpha4-integrin effect, pharmaceutical compositions containing them and their use | |
| HUP0203939A3 (en) | Pharmaceutical compounds and compositions containing them and their use | |
| IL156389A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL154817A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL145757A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL145756A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL150449A0 (en) | Aniline derivatives and pharmaceutical compositions containing the same | |
| IL152094A0 (en) | Ecteinascidin derivatives and pharmaceutical compositions containing the same | |
| IL152846A0 (en) | Pyridazinone derivatives and pharmaceutical compositions containing the same | |
| HUP0301713A3 (en) | Pharmaceutical compositions containing propenone derivatives and their use | |
| IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
| HUP0303184A3 (en) | Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them | |
| HUP0303204A3 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing them | |
| HUP0302397A3 (en) | Heterocyclic compounds and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC9A | Change of name, address |
Owner name: ASUBIO PHARMA CO. , LTD., JP Free format text: FORMER OWNER(S): SUNTORY LIMITED, JP; DAIICHI ASUBIO PHARMA CO., LTD., JP; DAIICHI SUNTORY PHARMA CO., LTD., JP |
|
| FD9A | Lapse of provisional protection due to non-payment of fees |